Sign in
Facet browsing currently unavailable
Page 4 of 4003 results
Sort by: relevance publication year
|
Moving Along the Yellow Brick (Card) Road? JOURNAL ARTICLE published October 2013 in Drug Safety |
|
Comment on: Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System JOURNAL ARTICLE published May 2021 in Drug Safety |
|
Erratum to: The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010 JOURNAL ARTICLE published May 2014 in Drug Safety |
|
Benzodiazepine Use and Risk of Acute Angle-Closure Glaucoma: A Population-Based Case-Crossover Study JOURNAL ARTICLE published June 2020 in Drug Safety |
|
Do Non-Nucleoside Reverse Transcriptase Inhibitors Contribute to Lipodystrophy? JOURNAL ARTICLE published 2005 in Drug Safety |
|
Timing Matters: A Machine Learning Method for the Prioritization of Drug–Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure JOURNAL ARTICLE published 30 April 2024 in Drug Safety |
|
Use of an On-demand Drug–Drug Interaction Checker by Prescribers and Consultants: A Retrospective Analysis in a Swiss Teaching Hospital JOURNAL ARTICLE published June 2013 in Drug Safety |
|
Post-Marketing Regulation of Medicines Withdrawn from the Market Because of Drug-Attributed Deaths: An Analysis of Justification JOURNAL ARTICLE published May 2017 in Drug Safety |
|
Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0) JOURNAL ARTICLE published January 2019 in Drug Safety Research funded by National Heart, Lung, and Blood Institute (R01HL125089) |
|
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions JOURNAL ARTICLE published September 2020 in Drug Safety |
|
Impact of Vaccine Hesitancy on Onset, Severity and Type of Self-reported Adverse Events: A French Cross-Sectional Survey JOURNAL ARTICLE published October 2022 in Drug Safety Research funded by Agence nationale de la recherche (ANR 20-COV8-0009-01) | H2020 European Research Council (JITSUVAX) |
|
Exploratory Study of Signals for Asthma Drugs in Children, Using the EudraVigilance Database of Spontaneous Reports JOURNAL ARTICLE published January 2020 in Drug Safety |
|
Comment on: “Desideratum for Evidence-Based Epidemiology” JOURNAL ARTICLE published January 2015 in Drug Safety |
|
Detecting Adverse Drug Reactions Caused By Drug-Drug Interaction in a Spontaneous Reporting Database JOURNAL ARTICLE published 2008 in Drug Safety |
|
Moclobemide, Citalopram and Hyponatraemia JOURNAL ARTICLE published 2008 in Drug Safety |
|
Implementing Signal Detection Methodology in a Medium Sized Company JOURNAL ARTICLE published 2007 in Drug Safety |
|
Safety profile of Etoricoxib as used in General Practice in England: Results of a Prescription-Event Monitoring (PEM) study JOURNAL ARTICLE published 2006 in Drug Safety |
|
Peripheral Neuropathy during Infliximab Therapy for Rheumatoid Arthritis JOURNAL ARTICLE published 2008 in Drug Safety |
|
Comment on “Evaluation of Potential Drug–Drug Interactions in Adults in the Intensive Care Unit: A Systematic Review and Meta-analysis” JOURNAL ARTICLE published February 2020 in Drug Safety |
|
Adverse Effects of Monobactams and Carbapenems JOURNAL ARTICLE published May 1995 in Drug Safety |